Abstract: Provided herein are proteins comprising one monovalent human TfR binding domain ("human TfR binding proteins"), proteins comprising one monovalent mouse TfR binding domain ("mouse TfR binding proteins"), conjugates comprising such human or mouse TfR binding proteins, e.g., human TfR binding proteins-dsRNA conjugates, pharmaceutical compositions comprising human TfR binding proteins or conjugates, and methods of treating CNS diseases (e.g., neurodegenerative disease such as neurodegenerative synucleinopathy or tauopathy) using human TfR binding proteins or conjugates.
| # | Name | Date |
|---|---|---|
| 1 | 202517017256-STATEMENT OF UNDERTAKING (FORM 3) [27-02-2025(online)].pdf | 2025-02-27 |
| 3 | 202517017256-Sequence Listing in PDF [27-02-2025(online)].pdf | 2025-02-27 |
| 4 | 202517017256-REQUEST FOR EXAMINATION (FORM-18) [27-02-2025(online)].pdf | 2025-02-27 |
| 5 | 202517017256-POWER OF AUTHORITY [27-02-2025(online)].pdf | 2025-02-27 |
| 6 | 202517017256-FORM 18 [27-02-2025(online)].pdf | 2025-02-27 |
| 7 | 202517017256-FORM 1 [27-02-2025(online)].pdf | 2025-02-27 |
| 8 | 202517017256-DRAWINGS [27-02-2025(online)].pdf | 2025-02-27 |
| 9 | 202517017256-DECLARATION OF INVENTORSHIP (FORM 5) [27-02-2025(online)].pdf | 2025-02-27 |
| 10 | 202517017256-COMPLETE SPECIFICATION [27-02-2025(online)].pdf | 2025-02-27 |
| 11 | 202517017256-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [27-02-2025(online)].pdf | 2025-02-27 |
| 12 | 202517017256-RELEVANT DOCUMENTS [06-03-2025(online)].pdf | 2025-03-06 |
| 13 | 202517017256-MARKED COPIES OF AMENDEMENTS [06-03-2025(online)].pdf | 2025-03-06 |
| 14 | 202517017256-FORM 13 [06-03-2025(online)].pdf | 2025-03-06 |
| 15 | 202517017256-AMMENDED DOCUMENTS [06-03-2025(online)].pdf | 2025-03-06 |
| 16 | 202517017256-Proof of Right [21-08-2025(online)].pdf | 2025-08-21 |
| 17 | 202517017256-FORM 3 [25-08-2025(online)].pdf | 2025-08-25 |